Fisher & Paykel Healthcare has downgraded its earnings guidance by $5-10 million for the financial year ended March 31, 2019, due to the legal costs it expects to incur in contesting a US lawsuit.
At its annual meeting last month, chief executive Lewis Gradon told shareholders that assuming a
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
